ATP6V0C competes with Von Hippel-Lindau protein in hypoxia-inducible factor 1α (HIF-1α) binding and mediates HIF-1α expression by bafilomycin A1

Molecular Pharmacology

Volumn 71, Issue 3, 2007, Pages 942-948

  Lim, Ji Hong ^a   Park, Jong Wan ^a   Sung, Joon Kim ^a   Kim, Myung Suk ^a   Park, Sang Ki ^b   Johnson, Randall S ^b   Chun, Yang Sook ^a  

^a Seoul National University College of Medicine   (South Korea)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BAFILOMYCIN A1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; PROTEIN SUBUNIT; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATASE; SUBUNIT C IN V0 SECTOR OF PROTON TRANSPORTING ADENOSINE TRIPHOSPHATASE; UNCLASSIFIED DRUG; VON HIPPEL LINDAU PROTEIN;

AMINO TERMINAL SEQUENCE; ANTINEOPLASTIC ACTIVITY; ARTICLE; ATTENUATION; BINDING SITE; CELL NUCLEUS; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG PROTEIN BINDING; DRUG TARGETING; EMBRYO; GENE EXPRESSION; HUMAN; HUMAN CELL; INTRACELLULAR TRANSPORT; KNOCKOUT GENE; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN LOCALIZATION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; PROTEIN STRUCTURE; PROTEIN TARGETING;

AMINO ACID MOTIFS; BINDING, COMPETITIVE; ENZYME INHIBITORS; HUMANS; HYDROGEN-ION CONCENTRATION; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MACROLIDES; VACUOLAR PROTON-TRANSLOCATING ATPASES; VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN;

EID: 33847135757     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.106.030296     Document Type: Article

References (39)

1. Bae MK, Ahn MY, Jeong JW, Bae MH, Lee YM, Bae SK, Park JW, Kim KR, and Kim KW (2002) Jab1 interacts directly with HIF-1α and regulates its stability. J Biol Chem 277:9-12.
2. Baek JH, Mahon PC, Oh J, Kelly B, Krishnamachary B, Pearson M, Chan DA, Giaccia AJ, and Semenza GL (2005) OS-9 interacts with hypoxia-inducible factor 1alpha and prolyl hydroxylases to promote oxygen-dependent degradation of HIF-1alpha. Mol Cell 17:503-512.
3. Birner P, Schindl M, Obermair A, Plank C, Breitenecker G, and Oberhuber G (2000) Overexpression of hypoxia-inducible factor 1alpha is a marker for an unfavorable prognosis in early-stage invasive cervical cancer. Cancer Res 60:4693-4696.
4. Bowman EJ, Graham LA, Stevens TH, and Bowman BJ (2004) The bafilomycin/concanamycin binding site in subunit c of the V-ATPases from Neurospora crassa and Saccharomyces cerevisiae. J Biol Chem 279:33131-33138.
5. Bowman EJ, Siebers A, and Altendorf K (1988) Bafilomycins: a class of inhibitors of membrane ATPases from microorganisms, animal cells, and plant cells. Proc Natl Acad Sci USA 85:7972-7976.
6. Bruick RK and McKnight SL (2001) A conserved family of prolyl-4-hydroxylases that modify HIF. Science (Wash DC) 294:1337-1340.
7. Carmeliet P, Dor Y, Herbert JM, Fukumura D, Brusselmans K, Dewerchin M, Neeman M, Bono F, Abramovitch R, Maxwell P, et al. (1998) Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature (Lond) 394:485-490.
8. Chun YS, Choi E, Yeo EJ, Lee JH, Kim MS, and Park JW (2001) A new HIF-1 alpha variant induced by zinc ion suppresses HIF-1-mediated hypoxic responses. J Cell Sci 114:4051-4061.
9. Drose S and Altendorf K (1997) Bafilomycins and concanamycins as inhibitors of V-ATPases and P-ATPases. J Exp Biol 200:1-8.
10. Epstein AC, Gleadle JM, McNeill LA, Hewitson KS, O'Rourke J, Mole DR, Mukherji M, Metzen E, Wilson MI, Dhanda A, et al. (2001) C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 107:43-54.
11. Finbow ME, Goodwin SF, Meagher L, Lane NJ, Keen J, Findlay JB, and Kaiser K (1994) Evidence that the 16 kDa proteolipid (subunit c) of the vacuolar H(+)-ATPase and ductin from gap junctions are the same polypeptide in Drosophila and Manduca: molecular cloning of the Vha16k gene from Drosophila. J Cell Sci 107:1817-1824.
12. Forgac M (1989) Structure and function of vacuolar class of ATP-driven proton pumps. Physiol Rev 69:765-796.
13. Goldstein DJ, Andresson T, Sparkowski JJ, and Schlegel R (1992) The BPV-1 E5 protein, the 16 kDa membrane pore-forming protein and the PDGF receptor exist in a complex that is dependent on hydrophobic transmembrane interactions. EMBO (Eur Mol Biol Organ) J 11:4851-4859.
14. Greijer AE and van der Wall E (2004) The role of hypoxia inducible factor 1 (HIF-1) in hypoxia induced apoptosis. J Clin Pathol 57:1009-1014.
15. Hegyi P, Rakonczay Z Jr, Gray MA, and Argent BE (2004) Measurement of intracellular pH in pancreatic duct cells: a new method for calibrating the fluorescence data. Pancreas 28:427-434.
16. 2-dependent degradation domain via the ubiquitin-proteasome pathway. Proc Natl Acad Sci USA 95:7987-7992.
17. o subunit c. J Biol Chem 277:40544-40548.
18. Isaacs JS, Jung YJ, and Neckers L (2004) Aryl hydrocarbon nuclear translocator (ARNT) promotes oxygen-independent stabilization of hypoxia-inducible factor-1α by modulating an Hsp90-dependent regulatory pathway. J Biol Chem 279:16128-16135.
19. Ivan M, Kondo K, Yang H, Kim W, Valiando J, Ohh M, Salic A, Asara JM, Lane WS, and Kaelin WG Jr (2001) HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science (Wash DC) 292:464-468.
20. 2-regulated prolyl hydroxylation. Science (Wash DC) 292:468-472.
21. Jiang BH, Rue E, Wang GL, Roe R, and Semenza GL (1996) Dimerization, DNA binding, and transactivation properties of hypoxia-inducible factor 1. J Biol Chem 271:17771-17778.
22. Jiang BH, Zheng JZ, Leung SW, Roe R, and Semenza GL (1997) Transactivation and inhibitory domains of hypoxia-inducible factor 1alpha. Modulation of transcriptional activity by oxygen tension. J Biol Chem 272:19253-19260.
23. Kamura T, Sato S, Iwai K, Czyzyk-Krzeska M, Conaway RC, and Conaway JW (2000) Activation of HIF1alpha ubiquitination by a reconstituted von Hippel-Lindau (VHL) tumor suppressor complex. Proc Natl Acad Sci USA 97:10430-10435.
24. Katschinski DM, Le L, Schindler SG, Thomas T, Voss AK, and Wenger RH (2004) Interaction of the PAS B domain with HSP90 accelerates hypoxia-inducible factor-1alpha stabilization. Cell Physiol Biochem 14:351-360.
25. Koshiji M and Huang LE (2004) Dynamic balancing of the dual nature of HIF-1alpha for cell survival. Cell Cycle 3:853-854.
26. +-ATPase 16-kDa subunit results in the Triton X-100-insoluble aggregation of β1 integrin and reduction of its cell surface expression. J Biol Chem 279:53007-53014.
27. Lim JH, Park JW, Kim MS, Park SK, Johnson RS, and Chun YS (2006) Bafilomycin induces the p21-mediated growth inhibition of cancer cells under hypoxic conditions by expressing HIF-1α. Mol Pharmacol 70:1856-1865.
28. Mack FA, Rathmell WK, Arsham AM, Gnarra J, Keith B, and Simon MC (2003) Loss of pVHL is sufficient to cause HIF dysregulation in primary cells but does not promote tumor growth. Cancer Cell 3:75-88.
29. Masson N, Willam C, Maxwell PH, Pugh CW, and Ratcliffe PJ (2001) Independent function of two destruction domains in hypoxia-inducible factor-alpha chains activated by prolyl hydroxylation. EMBO (Eur Mol Biol Organ) J 20:5197-5206.
30. Maxwell PH, Wiesener MS, Chang GW, Clifford SC, Vaux EC, Cockman ME, Wykoff CC, Pugh CW, Maher ER, and Ratcliffe PJ (1999) The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature (Lond) 399:271-275.
31. Moon EJ, Jeong CH, Jeong JW, Kim KR, Yu DY, Murakami S, Kim CW, and Kim KW (2004) Hepatitis B virus X protein induces angiogenesis by stabilizing hypoxia-inducible factor-1alpha. FASEB J 18:382-384.
32. Ohkuma S, Shimizu S, Noto M, Sai Y, Kinoshita K, and Tamura H (1993) Inhibition of cell growth by bafilomycin A1, a selective inhibitor of vacuolar H(+)-ATPase. In Vitro Cell Dev Biol Anim 29:862-866.
33. Ohta T, Arakawa H, Futagami F, Fushida S, Kitagawa H, Kayahara M, Nagakawa T, Miwa K, Kurashima K, Numata M, et al. (1998) Bafilomycin A1 induces apoptosis in the human pancreatic cancer cell line Capan-1. J Pathol 185:324-330.
34. Ravi R, Mookerjee B, Bhujwalla ZM, Sutter CH, Artemov D, Zeng Q, Dillehay LE, Madan A, Semenza GL, and Bedi A (2000) Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha. Genes Dev 14:34-44.
35. Ryan HE, Poloni M, McNulty W, Elson D, Gassmann M, Arbeit JM, and Johnson RS (2000) Hypoxia-inducible factor-1alpha is a positive factor in solid tumor growth. Cancer Res 60:4010-4015.
36. Semenza GL (2000) HIF-1: mediator of physiological and pathophysiological responses to hypoxia. J Appl Physiol 88:1474-1480.
37. Silver RB (1998) Ratio imaging: practical considerations for measuring intracellular calcium and pH in living tissue. Methods Cell Biol 56:237-251.
38. Zagzag D, Zhong H, Scalzitti JM, Laughner E, Simons JW, and Semenza GL (2000) Expression of hypoxia-inducible factor 1alpha in brain tumors: association with angiogenesis, invasion, and progression. Cancer 88:2606-2618.
39. Zhong H, De Marzo AM, Laughner E, Lim M, Hilton DA, Zagzag D, Buechler P, Isaacs WB, Semenza GL, and Simons JW (1999) Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. Cancer Res 59:5830-5835.